Takeda Pharmaceutical Co Ltd TKPHF:OTCPK

*Data is delayed | Exchange | USD
Last | 05/09/24 EDT
26.83UNCH (UNCH)
Volume
22
52 week range
25.04 - 33.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.83
  • 52 Week High33.09
  • 52 Week High Date05/11/23
  • 52 Week Low25.04
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap41,616.12M
  • Shares Out1,569.01M
  • 10 Day Average Volume59,018
  • Dividend1.21
  • Dividend Yield4.51%
  • Beta-
  • YTD % Change-6.61

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.83
  • 52 Week High33.09
  • 52 Week High Date05/11/23
  • 52 Week Low25.04
  • 52 Week Low Date04/25/24
  • Market Cap41,616.12M
  • Shares Out1,569.01M
  • 10 Day Average Volume59,018
  • Dividend1.21
  • Dividend Yield4.51%
  • Beta-
  • YTD % Change-6.61

RATIOS/PROFITABILITY

  • EPS (TTM)0.61
  • P/E (TTM)43.99
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Costa Saroukos
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan